Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:
Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunology
Mechanisms of induction, regulation and termination of innate and adaptive immunity
Intercellular communication, cooperation and regulation
Intracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)
Mechanisms of action of the cells and molecules of the immune system
Structural analysis
Development of the immune system
Comparative immunology and evolution of the immune system
"Omics" studies and bioinformatics
Vaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)
Technical developments



Articles based primarily on studies in silico must adhere to the following principles; (i) The article must report novel analytical tools, approaches and/or databases rather than using publicly available ones; or (ii) The article must include substantial experimental validation of the conclusions obtained in silico.

Manuscripts related to regulatory RNA (e.g. microRNAs, lncRNAs or circRNAs) are welcome but please note: (i) they must show clear physiological relevance supported by in vivo results or clinical observations; (ii) Correlations between regulatory RNA expression with human diseases should be experimentally validated; (iii) Functions associated with the regulatory RNAs must within the scope of the journal i.e. inflammation and/or immune responses.

To be acceptable for publication, studies that describe correlations between disease and genetic polymorphisms would normally be required to include novel mechanistic findings underlying the associations.


Clinical studies correlating disease and measurements of a molecule or cell type would likewise not be suitable for publication without novel mechanistic insights.


Studies describing pharmacological agents are welcome if they provide significant novelty on the mechanisms of action.

Research Articles
Review articles 

Editor-in-Chief
J. Villadangos
The University of Melbourne Department of Microbiology and Immunology, Melbourne, Victoria, Australia
Associate Editors
C. Gao
Jinan, China
L.J. Gershwin
Davis, California, United States
F Granucci
Milano, Italy
A. Lopata
Townsville, Australia
J. D. Mintern
Parkville, Australia
V. Mulero
Murcia, Spain
A.W. Purcell
Clayton, Australia
P. Thomas
Memphis, Tennessee, United States
T. M. Woodruff
Brisbane, Queensland, Australia
Honorary Editor
M.R. Daha
Leiden, Netherlands
Advisory Editors
J.P. Atkinson
Saint Louis, Missouri, United States
J.S. Ayres
La Jolla, California, United States
X.T. Cao
Beijing, China
M. Daeron
Paris, France
A. Erdei
Budapest, Hungary
A. Ferreira
Santiago de Chile, Chile
Z. Fishelson
Tel Aviv, Israel
T. Fujita
Fukushima, Japan
G.J. Hämmerling
Heidelberg, Germany
C. Kemper
Bethesda, Maryland, United States
P.-M. Kloetzel
Berlin, Germany
P.H. Krammer
Heidelberg, Germany
M-P. Lefranc
Montpellier, France
H-G. Ljunggren
Stockholm, Sweden
D.H. Margulies
Bethesda, Maryland, United States
S. Meri
HELSINKI, Finland
M. Montoya
Madrid, Spain
P.B. Morgan
Cardiff, United Kingdom
S. Morrison
Los Angeles, California, United States
P.A. Ramsland
Melbourne, Australia
C.J. Secombes
Aberdeen, United Kingdom
D.D. Taub
Washington, District of Columbia, United States
E. Vivier
Marseille, France
P.F. Zipfel
Jena, Germany